{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:10Z","timestamp":1753890910609,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>A boy is presented in whom Down Syndrome mosaicism and spinal muscular atrophy by overlapping clinical symptoms delayed the diagnosis and caused complicated motor development. The boy from the first pregnancy was delivered vaginally, week 37, Apgar 10, birth weight 3,650\u00a0g. The mother, aged 30, had no family history of Down Syndrome or neuromuscular diseases. Primary diagnosis at the age of 3\u00a0weeks: unbalanced male karyotype -mos 47, XY+21 [22]\/46, XY. At 20\u00a0months, the parents observed the disappearance of the high kneeling function and asked for a neurologist\u2019s consultation. The neurological examination showed symmetrically reduced muscle tone and symmetrically weakened knee and ankle tendon reflexes. The physiotherapeutic assessment revealed a symmetrical weakening of muscle strength and hand tremor (features characteristic of patients with spinal muscular atrophy). The final diagnosis, set at the age of 27\u00a0months, was thus the mosaic form of Down Syndrome and spinal muscular atrophy type 2.<\/jats:p>","DOI":"10.3389\/fgene.2024.1483903","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:30:33Z","timestamp":1732257033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Atypical motor development in a patient with the mosaic form of Down syndrome and spinal muscular atrophy type 2- long-term observation"],"prefix":"10.3389","volume":"15","author":[{"given":"Ewa","family":"Gajewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u0119drzej","family":"Flici\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Sobieska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Michalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"\u017barowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Steinborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3390\/biomedicines10123187","article-title":"Prospective analysis of functional and structural changes in patients with spinal muscular atrophy\u2014a pilot study","volume":"10","author":"Bieniaszewska","year":"2022","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8962","DOI":"10.3390\/ijms22168962","article-title":"Drug discovery of spinal muscular atrophy (SMA) from the computational perspective: a comprehensive review","volume":"22","author":"Chong","year":"2021","journal-title":"IJMS"},{"key":"B3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.nmd.2019.06.008","article-title":"Spinal muscular atrophy revisited","volume":"29","author":"Dubowitz","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/0883073811425423","article-title":"Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report","volume":"27","author":"Dunaway","year":"2012","journal-title":"J. Child. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nmd.2015.04.009","article-title":"209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 november 2014, heemskerk, The Netherlands","volume":"25","author":"Finkel","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"B7","first-page":"345","article-title":"Mental development in Down syndrome mosaicism","volume":"96","author":"Fishler","year":"1991","journal-title":"Am. J. Ment. Retard."},{"key":"B8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","article-title":"The children\u2019s hospital of Philadelphia infant test of neuromuscular disorders (CHOP INTEND): test development and reliability","volume":"20","author":"Glanzman","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/archdischild-2021-323605","article-title":"New treatments in spinal muscular atrophy","volume":"108","author":"Gowda","year":"2023","journal-title":"Arch. Dis. Child."},{"key":"B10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneurol.2010.373","article-title":"Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year","volume":"68","author":"Kaufmann","year":"2011","journal-title":"Arch. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"Kaufmann","year":"2012","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal muscular atrophy","volume":"33","author":"Kolb","year":"2015","journal-title":"Neurol. Clin."},{"key":"B13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.nmd.2006.03.015","article-title":"A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy","volume":"16","author":"Krosschell","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ridd.2016.09.019","article-title":"Growing up with Down syndrome: development from 6 months to 10.7 years","volume":"59","author":"Marchal","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"B15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An expanded version of the Hammersmith functional motor scale for SMA II and III patients","volume":"17","author":"O\u2019Hagen","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/mt.2013.276","article-title":"Dual masking of specific negative splicing regulatory elements resulted in maximal exon 7 inclusion of SMN2 gene","volume":"22","author":"Pao","year":"2014","journal-title":"Mol. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ajmg.a.36861","article-title":"Mosaicism for trisomy 21: a review","volume":"167","author":"Papavassiliou","year":"2015","journal-title":"Am. J Med Genet. Pt A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.a.32729","article-title":"The phenotype of persons having mosaicism for trisomy 21\/Down syndrome reflects the percentage of trisomic cells present in different tissues","author":"Papavassiliou","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0172346","DOI":"10.1371\/journal.pone.0172346","article-title":"Revised Hammersmith Scale for spinal muscular atrophy: a SMA specific clinical outcome assessment tool","volume":"12","author":"Ramsey","year":"2017","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000052118","article-title":"The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III","volume":"45","author":"Rudnik-Sch\u00f6neborn","year":"2001","journal-title":"Eur. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ncl.2015.07.006","article-title":"Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis","volume":"33","author":"Statland","year":"2015","journal-title":"Neurol. Clin."},{"key":"B23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12891-020-03710-7","article-title":"Cervical rotation, chest deformity and pelvic obliquity in patients with spinal muscular atrophy","volume":"21","author":"St\u0119pie\u0144","year":"2020","journal-title":"BMC Musculoskelet. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nmd.2021.02.011","article-title":"Filling the gaps in knowledge translation: physical therapy recommendations for individuals with spinal muscular atrophy compared to standard of care guidelines","volume":"31","author":"Trenkle","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","article-title":"A multi-source approach to determine SMA incidence and research ready population","volume":"264","author":"Verhaart","year":"2017","journal-title":"J. Neurol."},{"key":"B26","article-title":"Consensus statement for standard of care in spinal muscular atrophy","volume":"23","author":"Wang","year":"2007","journal-title":"J. Child. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/s0960-8966(99)00016-4","article-title":"59th ENMC international workshop: spinal muscular atrophies: recent progress and revised diagnostic criteria 17-19 april 1998, soestduinen, The Netherlands","volume":"9","author":"Zerres","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"Zerres","year":"1995","journal-title":"Arch. Neurol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1483903\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:30:35Z","timestamp":1732257035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1483903\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":28,"alternative-id":["10.3389\/fgene.2024.1483903"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1483903","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"article-number":"1483903"}}